Idaho Society of Clinical Oncology Starts Very first Statewide Personalized

of Begins
BOISE, Idaho, Feb. 9, 2015 /PRNewswire/ — Idaho Society of Clinical Oncology (ISCO) started its regular monthly statewide virtual customized tumor board on February two, 2015. The customized medication multidisciplinary tumor board was designed to advertise and&nbsp…
Read much more on SYS-CON Media (press release)

Oncolytics Biotech® Inc. Announces Filing for Orphan Drug Designation with the
Oncolytics&#39 clinical system involves a assortment of later-stage, randomized human trials in different indications using REOLYSIN®, its proprietary formulation of the human reovirus. For further information about Oncolytics, please go to: www …
Read more on SYS-CON Media (press release)

Tagged , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *